| Biosensing with nanofluidic diodes I Vlassiouk, TR Kozel, ZS Siwy Journal of the American Chemical Society 131 (23), 8211-8220, 2009 | 401 | 2009 |
| Point-of-care testing for infectious diseases: past, present, and future TR Kozel, AR Burnham-Marusich Journal of clinical microbiology 55 (8), 2313-2320, 2017 | 386 | 2017 |
| Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis JN Jarvis, A Percival, S Bauman, J Pelfrey, G Meintjes, GN Williams, ... Clinical infectious diseases 53 (10), 1019-1023, 2011 | 361 | 2011 |
| Characterization of a Murine Monoclonal Antibody toCryptococcus neoformans Polysaccharide That Is a Candidate for Human Therapeutic Studies A Casadevall, W Cleare, M Feldmesser, A Glatman-Freedman, ... Antimicrobial agents and chemotherapy 42 (6), 1437-1446, 1998 | 346 | 1998 |
| The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. TR Kozel, EC Gotschlich Journal of immunology (Baltimore, Md.: 1950) 129 (4), 1675-1680, 1982 | 336 | 1982 |
| Cryptococcus: from human pathogen to model yeast. J Heitman, TR Kozel, KJ Kwon-Chung, JR Perfect, A Casadevall Cryptococcus: from human pathogen to model yeast., 2010 | 298 | 2010 |
| Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes A Vecchiarelli, C Retini, C Monari, C Tascini, F Bistoni, TR Kozel Infection and immunity 64 (7), 2846-2849, 1996 | 224 | 1996 |
| Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes A Vecchiarelli, C Retini, D Pietrella, C Monari, C Tascini, T Beccari, ... Infection and immunity 63 (8), 2919-2923, 1995 | 223 | 1995 |
| Fungal diagnostics TR Kozel, B Wickes Cold Spring Harbor perspectives in medicine 4 (4), a019299, 2014 | 208 | 2014 |
| Activation of the complement system by pathogenic fungi TR Kozel Clinical microbiology reviews 9 (1), 34-46, 1996 | 203 | 1996 |
| Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis Y Han, TR Kozel, MX Zhang, RS MacGill, MC Carroll, JE Cutler The Journal of Immunology 167 (3), 1550-1557, 2001 | 181 | 2001 |
| Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis TR Kozel, RP Mastroianni Infection and immunity 14 (1), 62-67, 1976 | 177 | 1976 |
| Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils C Retini, A Vecchiarelli, C Monari, C Tascini, F Bistoni, TR Kozel Infection and immunity 64 (8), 2897-2903, 1996 | 169 | 1996 |
| Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide TR Kozel, J Cazin Jr Infection and Immunity 3 (2), 287-294, 1971 | 165 | 1971 |
| Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide JE Sanford, DM Lupan, AM Schlageter, TR Kozel Infection and immunity 58 (6), 1919-1923, 1990 | 159 | 1990 |
| Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation A Sahu, TR Kozel, MK Pangburn Biochemical Journal 302 (2), 429-436, 1994 | 153 | 1994 |
| Molecular architecture of the Cryptococcus neoformans capsule MA Gates, P Thorkildson, TR Kozel Molecular microbiology 52 (1), 13-24, 2004 | 146 | 2004 |
| Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae TR Kozel, MA Wilson, TP Farrell, SM Levitz Infection and immunity 57 (11), 3412-3417, 1989 | 146 | 1989 |
| Role of the capsule in phagocytosis of Cryptococcus neoformans TR Kozel, GST Pfrommer, AS Guerlain, BA Highison, GJ Highison Reviews of infectious diseases, S436-S439, 1988 | 144 | 1988 |
| Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid J Hansen, ES Slechta, MA Gates-Hollingsworth, B Neary, AP Barker, ... Clinical and Vaccine Immunology 20 (1), 52-55, 2013 | 142 | 2013 |
